Actively Recruiting

Phase 1
Age: 50Years +
MALE
ID07065682

Effectiveness of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction in Benign Prostatic Hyperplasia

Led by Universitas Diponegoro · Updated on 2025-07-15

84

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of combining dutasteride and aloe vera extract compared to dutasteride alone in men with benign prostatic hyperplasia (BPH). This phase 1 randomized, double-blind controlled trial aims to study changes in urinary flow, prostate size, and blood levels of vascular endothelial growth factor (VEGF), a marker related to blood vessel formation, over a 12-week treatment period. Participants receive daily doses of either dutasteride 0.5 mg with aloe vera extract 380 mg or dutasteride 0.5 mg alone for 12 weeks. The trial includes a control group receiving only dutasteride. The study employs quadruple masking to ensure unbiased assessment of treatment effects. During the study, participants will undergo tests to measure urine flow, prostate volume, and serum VEGF levels at the start and after 12 weeks of treatment. The researchers will monitor these outcomes to assess the impact of the treatments on BPH symptoms and related biological markers. The total participation duration is 12 weeks.

CONDITIONS

Brief Title

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

Who Can Participate

Age: 50Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with benign prostatic hyperplasia clinically or by imaging (prostate volume > 30 grams, maximum urine flow rate < 15 mL/s)
  • Willing to participate in the study
Not Eligible

You will not qualify if you...

  • Suspected prostatic cancer clinically or by imaging
  • Previous prostate surgery
  • Urinary retention
  • BPH complications such as urinary tract infections, kidney stones, or hydronephrosis
  • Use of alpha blockers or 5-alpha reductase inhibitors in the last 6 months
  • Routine use of aloe vera extract prior to the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 12 weeks

Participants receive daily doses of Dutasteride with or without Aloe Vera Extract to assess effects on benign prostatic hyperplasia.

Visits at baseline and periodically during the 12 weeks

Trial Site Locations

Total: 1 location

1

RSUD Karawang

Karawang, West Java, Indonesia

Actively Recruiting

Loading map...

Research Team

A

Achmad Rizky Herda Pratama dr. Achmad Rizky Herda Pratama, Sp.U, S.H, Urologist

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Single-center, Single-arm Study to Evaluate the Safety and...

BPH (Benign Prostatic Hyperplasia)

Actively Recruiting

1 location

Prospective Randomized Comparative Study Evaluating Outcomes...

BPH (Benign Prostatic Hyperplasia)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here